Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Lymphoblastic Leukaemia

Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation

Abstract

Adult T cell leukemia/lymphoma (ATL) is a poor prognosis T cell malignancy. In order to improve the outcome, we employed allogeneic stem cell transplantation (allo-SCT) for ATL in 10 patients, nine of whom were from HLA-identical siblings and one from an unrelated donor. Conditioning regimens varied among the patients except that all received total body irradiation. The patients tolerated the regimens well with mild, if any toxicity, and engraftment occurred in all cases. Median leukemia-free survival after allo-SCT was 17.5+ months (range 3.7–34.4+). Six of the 10 patients developed acute GVHD (one case each with grade I, III or IV, and three cases with grade II) and three patients developed extensive chronic GVHD. Four patients died after allo-SCT during the study period from either acute GVHD (grade IV), pneumonitis, gastrointestinal bleeding or renal insufficiency. Two of the 10 cases with no symptoms of GVHD relapsed with clinical ATL. These results strongly suggest that allo-SCT may improve the survival in ATL if a controlled degree of GVHD develops. Bone Marrow Transplantation (2001) 27, 15–20.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Uchiyama T, Yodoi J, Sagawa K et al. Adult T-cell leukemia: clinical and hematological features of 16 cases Blood 1977 50: 481–492

    CAS  PubMed  Google Scholar 

  2. Poiesz BJ, Ruscetti FW, Gazdar AF et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma Proc Natl Acad Sci USA 1980 77: 7415–7419

    Article  CAS  Google Scholar 

  3. Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera Proc Natl Acad Sci USA 1981 78: 6476–6480

    Article  CAS  Google Scholar 

  4. Yoshida M, Miyoshi I, Hinuma Y . Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease Proc Natl Acad Sci USA 1982 79: 2031–2035

    Article  CAS  Google Scholar 

  5. Shimoyama M, Ota K, Kikuchi M et al. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia J Clin Oncol 1988 6: 1088–1097

    Article  CAS  Google Scholar 

  6. Gill PS, Harrington WJ, Kaplan MH et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine New Engl J Med 1995 332: 1744–1748

    Article  CAS  Google Scholar 

  7. Taguchi H, Kinoshita K, Takatsuki K et al. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support J Acquir Immune Defic Syndr Hum Retrovirol 1996 12: 182–186

    Article  CAS  Google Scholar 

  8. Hanada S, Utsunomiya A, Suzuki S et al. Treatment for adult T-cell leukemia Cancer Chemother Pharmacol 1997 40: (Suppl) S47–S50

    Article  Google Scholar 

  9. Shimoyama M . The Lymphoma Study Group: diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma Br J Haematol 1991 79: 428–437

    Article  CAS  Google Scholar 

  10. Kato S, Nishimura J, Muta K et al. Overexpression of P-glycoprotein in adult T-cell leukemia Lancet 1990 336: 573

    Article  CAS  Google Scholar 

  11. Kuwazuru Y, Hanada S, Furukawa T et al. Expression of P-glycoprotein in adult T-cell leukemia cells Blood 1992 76: 2065–2071

    Google Scholar 

  12. Ikeda K, Oka M, Yamada Y et al. Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes Int J Cancer 1999 82: 599–604

    Article  CAS  Google Scholar 

  13. Sobue R, Yamauchim T, Miyamura K et al. Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation Bone Marrow Transplant 1987 2: 441–444

    CAS  PubMed  Google Scholar 

  14. Ljungman P, Lawler M, Asj B et al. Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia Br J Haematol 1994 88: 403–405

    Article  CAS  Google Scholar 

  15. Borg A, Liu Yin JA, Johnson PRE et al. Successful treatment of HTLV-1-associated adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation Br J Haematol 1996 94: 713–715

    Article  CAS  Google Scholar 

  16. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP . Continuous fluorescence monitoring of rapid cycle DNA amplification Biotechniques 1997 22: 130–138

    Article  CAS  Google Scholar 

  17. Kaplan E, Meier P . Nonparametric estimations from incomplete observations Am Stat Assoc J 1958 53: 457–481

    Article  Google Scholar 

  18. Kreitman RJ, Wilson WH, White JD et al. Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38(LMB-2) in patients with hematologic malignancies J Clin Oncol 2000 18: 1622–1636

    Article  CAS  Google Scholar 

  19. Tsukasaki K, Maeda T, Arimura K et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature Bone Marrow Transplant 1999 23: 87–89

    Article  CAS  Google Scholar 

  20. Kawa K, Nishiuchi R, Okamura T et al. Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation Lancet 1998 352: 1034–1035

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr I Sanada (Institute for Clinical Research, Kumamoto National Hospital), Dr E Ohtsuka (Second Department of Internal Medcine, Oita Medical University), Dr E Ohno (Department of Hematology, Oita Prefectural Hospital), Dr Y Nawa (Division of Internal Medicine and Hematology, Ehime Prefectural Central Hospital), Dr H Taji (Department of Hematology and Chemotherapy, Aichi Cancer Center) and Dr Y Atsuta (Division of Hematology, Japanese Red Cross Nagoya First Hospital) for providing information on ATL patients who received allo-SCT.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Utsunomiya, A., Miyazaki, Y., Takatsuka, Y. et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 27, 15–20 (2001). https://doi.org/10.1038/sj.bmt.1702731

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702731

Keywords

This article is cited by

Search

Quick links